Bone mass and gastrointestinal disease

Area of Science:

• Gastroenterology and Hepatology
• Endocrinology
• Bone Metabolism

Background:

• Gastrointestinal and liver diseases frequently impair nutrient absorption, leading to bone disease.
• Celiac disease, an inflammatory disorder triggered by gluten, causes small intestinal atrophy and malabsorption, particularly affecting calcium absorption.
• Low bone mineral density (BMD) is a common complication, with approximately 70% of adult celiac disease patients exhibiting reduced BMD.

Purpose of the Study:

• To review the impact of malabsorptive disorders, specifically celiac disease, on bone mineral density (BMD).
• To discuss the effectiveness of gluten-free diets in improving BMD in celiac disease patients.
• To emphasize the importance of screening for secondary bone disease in individuals with malabsorptive conditions.

Main Methods:

• Review of existing literature on celiac disease and its association with bone mineral density (BMD).
• Analysis of BMD changes in celiac disease patients treated with a gluten-free diet.
• Discussion of the implications of delayed diagnosis and treatment on peak bone mass attainment.

Main Results:

• Celiac disease significantly impacts calcium and vitamin D absorption, contributing to low BMD.
• Gluten-free diet improves BMD in celiac disease patients, but values often remain below normal.
• Failure to reach peak bone mass due to delayed diagnosis can explain persistent low BMD despite treatment.

Conclusions:

• Individuals with malabsorptive disorders, including celiac disease, are at high risk for secondary bone disease.
• Screening for bone disease is crucial in patients with malabsorptive conditions.
• Development of accessible BMD assessment methods is needed to facilitate early screening and intervention.